Search - tctmd.com

Displaying 901 - 920 of 1502

Sort: Relevancy | Date

Presentation TCT 2013

Drug-Eluting Balloons

Presenter: Jochen W?hrle

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in Germany?

Presenter: Bernhard Witzenbichler

October 28, 2013

Presentation TCT 2013

Design and Rationale of GLOBAL LEADERS

Presenter: Stephan Windecker

October 28, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds

Presenter: Robert-Jan van Geuns

October 28, 2013

Presentation TCT 2013

Yes! The European Union Has It Right

Presenter: Gilles Montalescot

October 28, 2013

Presentation TCT 2013

With Only One Small Randomized Trial, It Is Premature to Recommend This!

Presenter: Harvey White

October 28, 2013

Presentation TCT 2013

Treatment Considerations in Patients with Valvular Heart Disease Requiring PCI: Stent Selection, Pharmacotherapy, and Timing

Presenter: James Hermiller Jr

October 28, 2013

Presentation TCT 2013

The State-of the-Stent: US and Global Trends in Stent Use and Price, and Perspectives on Sociopolitical and Regulatory Forces

Presenter: Stephan Windecker

October 28, 2013

Presentation TCT 2013

The Evolution from Endeavor to Resolute: Stent Design Considerations and Results

Presenter: David Kandzari

October 28, 2013

Presentation TCT 2013

Synthesis of the ISAR Clinical Trials Comparing Different Stents in Different Settings

Presenter: Adnan Kastrati

October 28, 2013

Presentation TCT 2013

Synthesis of Clinical Trials with the Nobori Stent

Presenter: Takeshi Kimura

October 28, 2013

Presentation TCT 2013

Synthesis of Clinical Trials with the Biomatrix Stent

Presenter: Stephan Windecker

October 28, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Structural vs. Biologic DES Failure Modes: Pathologic Insights

Presenter: Michael Joner

October 28, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Rationale, Design and Status of the ISCHEMIA Trial

Presenter: David Maron

October 28, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

No! Aspirin and Ticagrelor Is a Much Better Option

Presenter: Emmanouil Brilakis

October 28, 2013

Presentation TCT 2013

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Presenter: Bo Lagerqvist

October 28, 2013

Presentation TCT 2013

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Presenter: Clemens von Birgelen

October 28, 2013

Advertisement

Drug-Eluting Balloons

Do I Really Need Bioresorbable Scaffolds in Germany?

Design and Rationale of GLOBAL LEADERS

Bioresorbable Vascular Scaffolds

Yes! The European Union Has It Right

With Only One Small Randomized Trial, It Is Premature to Recommend This!

Treatment Considerations in Patients with Valvular Heart Disease Requiring PCI: Stent Selection, Pharmacotherapy, and Timing

The State-of the-Stent: US and Global Trends in Stent Use and Price, and Perspectives on Sociopolitical and Regulatory Forces

The Evolution from Endeavor to Resolute: Stent Design Considerations and Results

Synthesis of the ISAR Clinical Trials Comparing Different Stents in Different Settings

Synthesis of Clinical Trials with the Nobori Stent

Synthesis of Clinical Trials with the Biomatrix Stent

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Structural vs. Biologic DES Failure Modes: Pathologic Insights

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Rationale, Design and Status of the ISCHEMIA Trial

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

No! Aspirin and Ticagrelor Is a Much Better Option

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content